In contrast to many prior studies, a study done with 2500 patients in the Henry Ford Hospital system found mortality benefit to early administration hydroxychloroquine to COVID-19 inpatients.

—

Send in a voice message: https://podcasters.spotify.com/pod/show/covidupdates/message